May 31 (Reuters) – Ireland-based Jazz Pharmaceuticals Plc
will buy Celator Pharmaceuticals Inc in a deal
valued at about $1.5 billion, to gain access to Celator’s
investigational product in…
The post Jazz Pharma to buy Celator in $1.5 bln deal appeared first on NASDAQ.